President Donald Trump made baffling remarks during a Monday press conference, claiming that pregnant women should avoid Tylenol, the brand name of acetaminophen, arguing that it was associated with a “very increased” risk of autism.

It was a new low for the Trump administration, leading to widespread outrage and incredulity among experts.

Then things got even sketchier when the New York Times revealed that the researcher behind the studies cited during Monday’s press conference had a financial interest in warning users against the use of Tylenol.